Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial.
Natsuaki M, Watanabe H, Morimoto T, Kozuma K, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Ishikawa T, Katoh H, Nishikawa H, Tamura T, Ono K, Yamamoto K, Ishihara T, Abe M, Taniguchi R, Ikari Y, Okada K, Kimura T. Natsuaki M, et al. Among authors: nishikawa h. EuroIntervention. 2023 Aug 7;19(5):e402-e413. doi: 10.4244/EIJ-D-23-00076. EuroIntervention. 2023. PMID: 37395475 Free article. Clinical Trial.
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K; j-Cypher Registry Investigators. Kimura T, et al. Among authors: nishikawa h. Circulation. 2009 Feb 24;119(7):987-95. doi: 10.1161/CIRCULATIONAHA.108.808311. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204304
Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry).
Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K; j-Cypher Registry Investigators. Nakagawa Y, et al. Among authors: nishikawa h. Am J Cardiol. 2010 Aug 1;106(3):329-36. doi: 10.1016/j.amjcard.2010.03.031. Epub 2010 Jun 18. Am J Cardiol. 2010. PMID: 20643241
Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
Tada T, Kimura T, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Nakashima H, Ito A, Siode N, Namura M, Inoue N, Nishikawa H, Nakao K, Mitsudo K; j-Cypher Registry Investigators. Tada T, et al. Among authors: nishikawa h. Am J Cardiol. 2011 Apr 15;107(8):1155-62. doi: 10.1016/j.amjcard.2010.12.013. Epub 2011 Feb 4. Am J Cardiol. 2011. PMID: 21296326 Free article.
Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
Kishi K, Kimura T, Morimoto T, Namura M, Muramatsu T, Nishikawa H, Hiasa Y, Isshiki T, Nobuyoshi M, Mitsudo K; j-Cypher Registry Investigators. Kishi K, et al. Among authors: nishikawa h. Circ Cardiovasc Interv. 2011 Aug;4(4):362-70. doi: 10.1161/CIRCINTERVENTIONS.111.961904. Epub 2011 Jun 28. Circ Cardiovasc Interv. 2011. PMID: 21712527 Free article.
Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
Tamura T, Kimura T, Morimoto T, Nakagawa Y, Furukawa Y, Kadota K, Tatami R, Kawai K, Sone T, Miyazaki S, Mitsudo K; j-Cypher Registry Investigators. Tamura T, et al. EuroIntervention. 2011 Sep;7(5):588-96. doi: 10.4244/EIJV7I5A95. EuroIntervention. 2011. PMID: 21930463 Free article.
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.
Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K; j-Cypher Registry Investigators. Kimura T, et al. Among authors: nishikawa h. Circulation. 2012 Jan 31;125(4):584-91. doi: 10.1161/CIRCULATIONAHA.111.046599. Epub 2011 Dec 27. Circulation. 2012. PMID: 22203694
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; RESET Investigators. Kimura T, et al. Among authors: nishikawa h. Circulation. 2012 Sep 4;126(10):1225-36. doi: 10.1161/CIRCULATIONAHA.112.104059. Epub 2012 Jul 23. Circulation. 2012. PMID: 22824435 Clinical Trial.
Comparison of five-year outcome of sirolimus-eluting stent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher registry).
Kato M, Kimura T, Morimoto T, Nishikawa H, Uchida F, Suzuki H, Hayashi Y, Kadota K, Mitsudo K; J-Cypher Registry Investigators. Kato M, et al. Among authors: nishikawa h. Am J Cardiol. 2012 Nov 1;110(9):1282-9. doi: 10.1016/j.amjcard.2012.06.032. Epub 2012 Jul 25. Am J Cardiol. 2012. PMID: 22835413
1,523 results